Request Deal Involvement

Casdin Capital led a $100m Series B funding round in C2i Genomics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

THE MARK FOUNDATION FOR CANCER RESEARCH

bidder

THE MARK FOUNDATION FOR CANCER RESEARCH

SECTION 32 (S32)

bidder

SECTION 32 (S32)

C2I GENOMICS

target

C2I GENOMICS

SILVER LAKE PARTNERS LP

bidder

SILVER LAKE PARTNERS LP

CASDIN CAPITAL

bidder

CASDIN CAPITAL

IGLOBE PARTNERS

bidder

IGLOBE PARTNERS

DRIEHAUS CAPITAL

bidder

DRIEHAUS CAPITAL

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

GORDON ASSET MANAGEMENT

bidder

GORDON ASSET MANAGEMENT

LIONBIRD

bidder

LIONBIRD

NFX

bidder

NFX

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Casdin Capital led a $100m Series B funding round in C2i Genomics.